key: cord-0819303-54l0fwhy
authors: Hadjistavropoulos, Heather D.; Peynenburg, Vanessa; Thiessen, David L.; Nugent, Marcie; Karin, Eyal; Staples, Lauren; Dear, Blake F.; Titov, Nickolai
title: Utilization, Patient Characteristics, and Longitudinal Improvements among Patients from a Provincially Funded Transdiagnostic Internet-delivered Cognitive Behavioural Therapy Program: Observational Study of Trends over 6 Years
date: 2021-04-12
journal: Can J Psychiatry
DOI: 10.1177/07067437211006873
sha: 6c0ff80804ff08687040f1fbddb9d3df1d990c80
doc_id: 819303
cord_uid: 54l0fwhy

OBJECTIVE: There is strong evidence supporting internet-delivered cognitive behaviour therapy (iCBT) and consequently growing demand for iCBT in Canada. Transdiagnostic iCBT that addresses both depression and anxiety is particularly promising as it represents an efficient method of delivering iCBT in routine care. The Online Therapy Unit, funded by the Saskatchewan government, has been offering transdiagnostic iCBT for depression and anxiety since 2013. In this article, to broadly inform implementation efforts, we examined trends in utilization, patient characteristics, and longitudinal improvements for patients receiving transdiagnostic iCBT over 6 years. METHODS: Patients who completed telephone screening between November 2013 and December 2019 were included in this observational study. Patients provided demographics and mental health history at screening and completed measures at pre-treatment, post-treatment and at 3- to 4-month follow-up. Treatment engagement and satisfaction were assessed. RESULTS: A total of 5,321 telephone screenings were completed and 4,283 of patients were accepted for treatment over the 6-year period (80.5% acceptance). The most common reason for referral to another service was high suicide risk/severe symptoms (47.1%). Examination of trends showed growing use of transdiagnostic iCBT over time (37% increase per year). There was remarkable stability in patient characteristics across years. Most patients were concurrently using medication (57.3%) with 11.9% reporting using iCBT while on a waiting list for face-to-face treatment highlighting the importance of integrating iCBT with other services. Consistent across years, large improvements in depression and anxiety symptoms were found and maintained at 3- to 4-month follow-up. There was strong patient engagement with iCBT and positive ratings of treatment experiences. CONCLUSIONS: As there is growing interest in iCBT in Canada, this large observational study provides valuable information for those implementing iCBT in terms of likely user characteristics, patterns of use, and improvements. This information has potential to assist with resource allocation and planning in Canada and elsewhere.

Depression and anxiety contribute significantly to the global disease burden, 1 but many Canadians do not receive treatment for their concerns. 2 Individuals face both structural (e.g., location) and attitudinal (e.g., stigma) barriers to treatment. 3 Public health crises, like COVID-19, highlight the need for digital mental health treatments. 4 Consequently, the Canadian government announced "an investment of $240.5 million to develop, expand, and launch virtual care and mental health tools to support Canadians." 5 Within the digital mental health field, there is enormous evidence supporting both diagnostic-specific and transdiagnostic (concurrent treatment of depression and anxiety) therapist-assisted internet-delivered cognitive behaviour therapy (iCBT). [6] [7] [8] [9] [10] [11] Although heterogeneity among iCBT programs exists, in routine practice, it is common for programs to begin with screening and for treatment materials to be presented over several months using online weekly lessons. In routine practice, it is also common for trained providers (e.g., therapist, psychologist) to offer support via weekly asynchronous emails and or telephone calls 10 and for programs to include persuasive design features such as automated emails. 12 While iCBT research emerged over 20 years ago, 13 within Canada, there has been limited access to publicly funded therapist-assisted iCBT programs coordinated with healthcare services. 14 One question that emerges is what can be expected longer-term when therapist-assisted iCBT is routinely and freely available.

One example of a well-researched publicly funded iCBT program in Canada is the Online Therapy Unit in Saskatchewan. The unit screens patients for, and delivers, an 8-week transdiagnostic iCBT program called the Wellbeing Course that was originally, developed, validated, and then implemented by MindSpot, an Australian digital mental health service. 11 The transdiagnostic program creates efficiency in implementing iCBT (e.g., reduces time to train therapists in and to allocate patients to diagnostic-specific programs) and has been integrated into Saskatchewan mental health care by encouraging physicians and clinicians to direct patients to this service when this meets patients' needs or when patients are on waiting lists. Furthermore, community mental health clinics have designated clinicians who deliver iCBT via the unit platform.

The Online Therapy Unit also has a research arm. Past research on the Wellbeing Course has shown outcomes are strong whether delivered by therapists who specialise in iCBT or by therapists who primarily deliver face-to-face treatment. 15, 16 Furthermore, outcomes are comparable with varying support (i.e., once-weekly support compares to optional support, 17, 18 twice-weekly support, 19 and one-business-day support 20 ). Still, other trials have studied therapist behaviours in iCBT [21] [22] [23] and outcomes of iCBT for alcohol misuse, 24 for various chronic health conditions, [25] [26] [27] [28] [29] [30] and for specific populations like postpartum depression/ anxiety 31 or university students. 32 With the growing imperative to offer iCBT in Canada, the purpose of this article is to examine patient characteristics as well as longitudinal improvements among patients screened for and offered transdiagnostic iCBT via the Online Therapy Unit over *6 years; there is no other such report of iCBT in routine care in Canada and to our knowledge only one other similar report from Australia, 33 which deserves replication. In this 7-year Australian study, utilization increased in the first 3 years and subsequently stabilized, with a higher demand for assessment services than iCBT. iCBT effects were stable across years. Over time, there was an increase in young adult users, Aboriginal or Torres Strait Islander, and individuals with anxiety.

As has been noted, "evaluation of trends over time in how mental health services are used can help guide decisions about resource allocation" 34 and program planning. 33 Specifically, monitoring trends helps identify user changes and gaps in care and informs new programming or care models (e.g., growth in younger users could suggest offering texting rather than telephone support). Examining trends also adds to evidence regarding iCBT in routine care as there are few reports of iCBT outcomes sustained over longer periods after initial implementation efforts conclude. 35 Research questions explored in this study were as follows: What growth will be observed in iCBT over time? Will users of iCBT change? Will there be stability in longitudinal symptom improvements over 6 years? Drawing on findings from Australia, 33 it was hypothesized there would be growth in iCBT over time and effects would be consistently large over the 6-year period. Hypotheses regarding changes in users of iCBT were exploratory.

Patients who requested iCBT between November 2013 and December 2019 are included in this uncontrolled observational cohort analysis. Ethics approval was obtained from the University of Regina Research Ethics Board. The article combines data across and between registered trials that examined the Wellbeing Course outcomes across settings (ISRCTN42729166), with motivational interviewing as a pre-treatment (NCT03684434) or with varying levels of support (ISRCTN14230906; NCT03304392; NCT03957330).

Participants learn about iCBT through various sources (which have remained consistent) including medical professionals (55.0%; n ¼ 2,928), mental health professionals (16.0%; n ¼ 851), word of mouth (13.0%; n ¼ 689), online sources (6.9%; n ¼ 367), printed materials (2.2%; n ¼ 115), media (2.5%, n ¼ 132), insurance providers (0.3%, n ¼ 14), or non-specified means (4.0%; n ¼ 214). Consistent across years, to be eligible for iCBT, patients have to identify as (1) 18 years of age, (2) Saskatchewan residents, (3) having >5 Patient Health Questionnaire 9-item (PHQ-9) 36 and/or >5 Generalized Anxiety Disorder Questionnaire 7-item (GAD-7) 37 , (4) having Internet access and computer comfort, and (5) a healthcare provider emergency contact. Individuals meeting any of the following are excluded: (1) high risk of suicide, past year suicide attempt, or mental health hospitalization; (2) unmanaged psychosis, mania, and or drug/alcohol problems; (3) > twice-monthly face-to-face therapy; (4) not in Saskatchewan for 8-week treatment; (5) seeking help for different problem; or (6) not interested in iCBT. As individuals with subthreshold symptoms benefit from iCBT, diagnosis is not required for iCBT. 38 

Prospective participants complete an online screening questionnaire capturing demographics and questionnaires listed below. Thereafter, participants complete a telephone interview further assessing inclusion/exclusion criteria. Individuals ineligible for iCBT are referred to alternative resources. Eligible participants provide verbal treatment consent over the telephone followed by digital consent on the platform.

All patients received the transdiagnostic iCBT Wellbeing Course (see Titov et al. for details 11 ), consisting of 5 lessons targeting anxiety and depression symptoms, released gradually over 8 weeks. Lessons consist of educational content, patient stories, and homework. Core strategies include monitoring physical, behavioural, and cognitive symptoms; thought challenging; controlled breathing; behavioural activation; graduated exposure; and relapse prevention. Additional resources (i.e., assertiveness, beliefs, communication, managing emergencies, mental skills, panic, post-traumatic stress, sleep, and structured problem solving/worry time) are also openly accessible throughout treatment. 11 

The Online Therapy Unit trained all therapists (n ¼ 132) who have a primary affiliation with the unit (n ¼ 46) or a government-funded Saskatchewan mental health clinic (n ¼ 86 therapists from 11 clinics). Therapists have backgrounds in social work (n ¼ 80), psychology (n ¼ 36), addictions (n ¼ 9), or nursing (n ¼ 7) and are either registered professionals (n ¼ 96) or supervised graduate students (n ¼ 36). On average, therapists included in this dataset treated 31 patients (SD ¼ 89.23; range ¼ 1 to 626). In March 2018, to improve coordination of iCBT, the Unit increased the numbers of therapists working half-to full-time and reduced the numbers of therapists with small caseloads. 22 

Therapists contact clients on a designated day once-weekly for 8 weeks, although in some trials the amount of contact has varied (e.g., optional, twice-weekly). [17] [18] [19] [20] Most contact includes asynchronous secure emails, with therapists spending 15 to 20 minutes composing messages after reviewing patient iCBT progress, symptom measures, and messages. Therapists also phone patients when there is a large symptom increase, messages suggest suicide risk, patients have not logged in for a week, and or a phone call would more easily address patient concerns. Across trials, therapists follow a treatment manual; regular audit and feedback is used to ensure compliance with procedures. 24 

All measures are administered pre-treatment, at 8 weeks, and 3 to 4 months post-treatment. There has been some minor variability in measures administered resulting in variable sample size for some measures. . The PHQ-9 is a 9-item questionnaire assessing depression over the past 2 weeks (range 0 to 27). 36 Scoring 10 suggests a likely depression diagnosis. 38 GAD-7. The GAD-7 is a 7-item questionnaire measuring anxiety over the past 2 weeks (range 0 to 21). 37 Scoring 8 suggests a likely generalized anxiety disorder diagnosis. 33

Panic Disorder Severity Scale Self-report (PDSS-SR). The PDSS-SR is 7-item panic disorder questionnaire (ranges 0 to 28). 39 Scoring 8 suggests a likely panic disorder diagnosis. 40 Social Interaction Anxiety Scale and Social Phobia Scale (SIAS-6/ SPS-6). The SIAS-6/SPS-6 are 6-item social anxiety measures (ranges 0 to 48). 41 SIAS-6 7 and SPS-6 2 suggest a likely social anxiety disorder diagnosis. 41 Kessler Distress Scale (K10). The K10 includes10 items of psychological distress (ranges 10 to 50). 42 Score > 21 suggests significant distress. 33 Sheehan Disability Scale (SDS). The SDS includes 3 items measuring disruption to work/school, social life, and family life 43 creating a 0 (unimpaired) to 30 (highly impaired) score.

Working Alliance Inventory-Short Revised (WAI-SR). The 12-item WAI-SR, administered at 8 weeks, resulted in a total working alliance score (range 15 to 60), and task, goal, and bond sub-scores (range 5 to 20). 44 Healthcare use. From October 2017 to September 2018, at pre-treatment and 4-month follow-up, patients completed 3-month healthcare use questions (i.e., physician, psychiatrist, mental health provider, ER/hospital admission and other medical/health provider).

At 8 weeks post-treatment, patients answered yes/no items about whether they would recommend the treatment to a friend, the course was worth their time, and they experienced negative treatment effects. Patients also rated satisfaction (1 to 5) with the course, materials, frequency and quality of therapist contact, confidence to manage symptoms, and motivation to seek future treatment.

iCBT engagement was assessed by examining number of patient messages, therapist messages, phone calls, and lessons accessed.

Data were analysed using SPSS version 26.0 with chi-square analyses of linear-by-linear associations (categorical variables) and analysis of variance (continuous variables) to assess yearly trends in patient characteristics, satisfaction, and engagement. As this study used data collected during and between trials, secondary analyses examined whether these variables differed by trials (see Supplementary Material).

Generalized estimating equation (GEE) models were run in R and examined symptoms from assessment to post-treatment to follow-up after controlling for enrolment year and therapist location. 45 Secondary analyses also controlled for trials. Consistent with intention-to-treat analyses, missing data were imputed before analysis. Clinically significant change was examined by year (and secondarily by trials) through percentage symptom changes from baseline, 46 and within-group Hedges g effect sizes using GEE estimated marginal means. Separate analyses were conducted for the overall sample and for patients in the clinical range at pre-treatment (i.e., PHQ-9 > 10, GAD-7 > 8, PDSS > 8, SIAS >7 and SPS > 2, K10 > 21, 33 and SDS > 11) . The SDS value was based on 1st quartile cut-off as no cut-off was identified. Clinical deterioration was defined as PHQ-9 increasing 6 and GAD-7 increasing 5 33 ; clinical recovery was defined as PHQ-9 decreasing 6 and GAD-7 decreasing 5, resulting in a patient moving from the clinical to the non-clinical range. 33 A Bonferroni correction was used for each set of analyses as a control for number of tests performed. Figure 1 shows the number and proportion of patients who were screened (n ¼ 5,321), started (n ¼ 4,283) and completed all treatment materials (n ¼ 2,831). Table 1 provides demographics for patients who started iCBT by year. There were no differences in patient characteristics over time, except for the proportion who indicated having children (range: 51.0% to 63.8%). Patient characteristics also did not differ by trial period (See Supplementary  Table 1) . Table 2 shows baseline symptom severity for patients who started iCBT each year remained stable (Supplementary  Material Table 2 also shows the clinical profile was stable across trials). Across years, 83.7% (n ¼ 3,352) of patients had depression and or anxiety in the clinical range and 60.7% (n ¼ 2,290) reported psychotropic medication use in the last 3 months. Table 3 shows means, tests of symptom reduction, effect sizes, and percentage reductions for the overall sample and those in the clinical range. Analysis revealed significant symptom reductions on all measures at post-treatment, which were maintained at follow-up. For those in the clinical range, effect sizes were large for all post-treatment and follow-up measures, except for social anxiety, which had a moderate post-treatment effect. A significant portion of patients demonstrated post-treatment recovery and very few experienced deterioration across years (see Table 4 ).

Year-to-year analysis of showed high engagement across measures and years (e.g., 80.4%; n ¼ 3,217 of patients accessed at least 4 lessons; see Table 4 ). Some significant differences were observed in number of emails and phone calls between therapists and patients over the years and across trials reflecting research trials that varied support levels (see Table 4 ; Supplementary Material Table 3 ).

Working alliance and satisfaction variables show strong patient satisfaction across all indicators over time (see Table 4 ). There was a significant increase in patients' WAI-SR total, bond, and goal scores over the years and related to research trials where there was increased therapist contact (see Table 4 , Supplementary Material Table 3 ).

For the sub-sample who completed healthcare questions at screening (n ¼ 655) and follow-up (n ¼ 453), there was no change in the proportion of patients who reported visits to a psychiatrist (16.6% vs. 16.6%), mental health professional (27% vs. 21.6%), medical or health professional (7.2% vs. 4.9%), or having an emergency room/hospital admission (4.7% vs. 2.6%). There was a reduction in visits to family physicians (61.2% vs. 32.5%; w2 (1, N ¼ 655) ¼ 88.16, P < 0.001) and patients not utilizing any service for mental health concerns (50.3% vs. 24.0%; w2 (1, N ¼ 655) ¼ 81.82, P < 0.001).

This observational cohort study adds to evidence related to patient features, engagement, satisfaction and longitudinal improvements in therapist-assisted transdiagnostic iCBT in routine care in Canada. Consistent with studies on iCBT in routine care in Australia, 10,33 large effect sizes were found across years on primary measures, distress, and disability that were maintained at follow-up. A considerable number of patients met criteria for recovery (55.7% for depression; 58.7% for anxiety), and deterioration rates were very low (1.3% for depression; 1.7% for anxiety). These findings demonstrate the stability in iCBT symptom improvements over time in routine care and after initial implementation efforts, which has rarely been reported in the literature with such large sample sizes and has not been examined in Canada to date. 35 The Online Therapy Unit showed significant growth in the numbers of patients completing telephone screens (average annual increase: 37.7%) and starting iCBT (average annual increase: 35.3%), indicating increasing demand for digital mental health services. This finding supports the Canadian Government announcement to fund virtual mental health tools, especially iCBT. It would be valuable to 49 and males 50 reflects a broader concern about lower mental health utilization in these populations and is not necessarily specific to iCBT. Of interest, there is considerable diversity in symptom severity among those seeking iCBT and iCBT programs need to take this into account (*16% did not have scores in the clinical range; 57.3% of patients were taking medication). Over 50% of patients were referred by physicians, suggesting iCBT is a valuable resource for physicians in managing patient needs. In the subsample of patients who completed healthcare use questions pre and post-ICBT, there was a decreased report of physician visits after completing iCBT (61.2% vs. 32.5%), highlighting the importance of coordinating iCBT with medical care and draws attention to the need for research on how iCBT impacts healthcare use.

Across years, patient engagement and satisfaction were excellent (e.g., 80% review most materials; 96.3% report iCBT was worth their time). There were some differences in the patient/therapist emails, phone calls, and working alliance observed across years, with supplementary analyses suggesting differences reflected research trials that offered varying degrees of therapist support. Importantly, this past research shows increasing therapist support beyond once weekly does not improve effects and in fact is associated with higher costs and operational challenges. 20, 21 Comparison with Wellbeing Course in Australia

The sample characteristics are similar to the Australian sample, 33 except a greater proportion of our patients reported concurrent medication use and treatment. Notably, patients in our sample were more likely to complete most treatment materials (80.4% vs. 67.1%), post-treatment measures (70.8% vs. 60.0%), and follow-up measures (60.3% vs. 39.3%). Lower completion rates in the Australian sample may be explained by higher pre-treatment symptom severity or differences in practices. For example, a large proportion of the Australian patients were seeking symptom consultation rather than iCBT, and users were permitted to access iCBT without first speaking to a therapist. A greater focus on consultation and system navigation is a potential avenue for the Online Therapy Unit in the future, especially since this represents an area of growth in Australia. Of note, the Australian group identified an increase in proportion of young adult users, Aboriginal or Torres Strait Islander, and those with anxiety, which we did not identify; these may be trends to watch that could impact programming. Notwithstanding the differences, the similarity in patient characteristics and longitudinal effects across the two countries is striking. The results provide promising evidence that with minor adaptations, iCBT may be used effectively across countries.

Post-treatment and follow-up data were missing for approximately 30% and 40% of patients, respectively, although rates of follow-up are higher than what is typical of routine care studies, 9,51-53 and a conservative approach was used to replace missing data. This study did not include a control group, although previous RCTs on the Wellbeing Course, 54 and many randomized controlled trials of iCBT have been undertaken. 6 Self-report measures were used rather than diagnostic interviews and key demographic characteristics (e.g., gender, sexual orientation) were not tracked, so certain groups may be under-represented. The results need to be considered in light of the fact that many patients use other services while using iCBT, and we used a brief measure of healthcare use for a subsample only; as such, it is impossible to fully ascertain whether participating in iCBT is associated with decreased use of other services, including face-to-face CBT, at follow-up. Finally, it is important to note we did not track additional resource use in the current study, and future research should explore how these resources contribute to outcomes.

In light of research showing many patients do not receive adequate quality or quantity of treatment 55 intensified by the COVID-19 pandemic, 56 the spotlight is on digital mental health services to improve treatment access. This study highlights growth can be expected in iCBT over time, and it is possible to sustain large effects, patient engagement, and satisfaction over time after initial iCBT implementation efforts have been employed. A strength of this study is its large sample size spanning 6 years, and the stability of symptom improvements from post-treatment to 3-to 4-month follow-up, engagement, and satisfaction over time. Publication of large studies like this one assists groups who are planning changes to mental health systems 33 and is important as there is no large health service databases to draw on related to iCBT. The findings highlight iCBT is not a replacement for other services, as *20% of patients seeking iCBT are referred to other services, and a high percentage of patients concurrently take medication; as such, iCBT needs to be woven into existing healthcare systems. The study identifies some gaps in service users, suggesting directions for improving reach of iCBT that represent important considerations for others implementing iCBT in Canada. The longitudinal effects observed in this large study may serve as a benchmark for the growing number of iCBT programs that are emerging in Canada. 14 Benchmarking is a common technique in routine practice that will allow groups implementing iCBT programs to compare effects across different programs 57 and can guide quality improvement efforts (e.g., encouraging programs with lower effects to improve care) as well as funding decisions.

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study

Perceived need for mental health care in Canada: results from the 2012 Canadian community health survey-mental health

Barriers to mental health treatment: results from the national comorbidity survey replication

The COVID-19 pandemic: the "black swan" for mental health care and a turning point for e-health

Prime Minister announces virtual care and mental health tools for Canadians

Internet interventions for adults with anxiety and mood disorders: a narrative umbrella review of recent meta-analyses

Internet-delivered psychological treatments: from innovation to implementation

Internet-delivered cognitive behavioural therapy for anxiety disorders community versus clinical service recruitment: meta-analysis

Effectiveness of Internet-based cognitive behaviour therapy for depression in routine psychiatric care

Effects of Internetbased cognitive behavioral therapy in routine care for adults in treatment for depression and anxiety: a systematic review and meta-analysis

MindSpot Clinic: an accessible, efficient, and effective online treatment service for anxiety and depression

Persuasive design does matter: a systematic review of adherence to web-based interventions

Internet interventions: past, present and future

Canadian Agency for Drugs and Technologies in Health. Internet-delivered cognitive behavioural therapy for major depressive disorder and anxiety disorders: an environmental scan. Environmental Scan

Transdiagnostic Internet-delivered cognitive behaviour therapy in Canada: an open trial comparing results of a specialized online clinic and nonspecialized community clinics

Implementation of Internet-delivered cognitive behaviour therapy within community mental health clinics: a process evaluation using the consolidated framework for implementation research

Randomized controlled trial of internet-delivered cognitive behaviour therapy comparing standard weekly versus optional weekly therapist support

Preference trial of Internet-delivered cognitive behaviour therapy comparing standard weekly versus optional weekly therapist support

A pragmatic factorial randomized controlled trial of transdiagnostic internet-delivered cognitive behavioural therapy: exploring benefits of homework reflection questionnaires and twice-weekly therapist support

Transdiagnostic Internet-delivered cognitive behaviour therapy with therapist support offered once-weekly or once-weekly supplemented with therapist support within one-business-day: pragmatic randomized controlled trial

Development of the internet-delivered cognitive behaviour therapy undesirable therapist behaviours scale (ICBT-UTBS)

Development and evaluation of a scale assessing therapist fidelity to guidelines for delivering therapistassisted Internet-delivered cognitive behaviour therapy

Audit and feedback of therapist-assisted Internet-delivered cognitive behaviour therapy with routine care: a quality improvement case study

Optimizing Internet-delivered cognitive behaviour therapy for alcohol misuse: a study protocol for a randomized factorial trial examining the effects of a pre-treatment assessment interview and health educator guidance

Internet-delivered cognitive behaviour therapy for chronic conditions: comparing low intensity delivery models

Guided Internet-delivered cognitive behaviour therapy for persons with spinal cord injury: a feasibility trial

Effectiveness, acceptability and feasibility of an internet-delivered cognitive behavioural pain management program in a routine online therapy clinic in Canada

Examination of an in internet-delivered cognitive behavioural pain management course for adults with fibroymyalgia: a randomized controlled trial

Making internet-delivered cognitive behaviour therapy scale for cancer survivors: a randomized non-inferiority trial of self-guided and technician-guided therapy

Efficacy of Internet-delivered cognitive behavioural therapy following an acute coronary event: a randomized controlled trial

Examining the effectiveness of transdiagnostic internet-delivered cognitive behaviour therapy in new mothers experiencing anxiety and depression

Internet-delivered cognitive behaviour therapy (ICBT) for post-secondary students

User characteristics and outcomes from a national digital mental health service: an observational study of registrants of the Australian MindSpot Clinic

Temporal trends in mental health service utilization across outpatient and acute care sectors: a population-based study from 2006 to 2014

A solution-focused research approach to achieve an implementable revolution in digital mental health

The PHQ-9: validity of a brief depression severity measure

A brief measure for assessing generalized anxiety disorder: the GAD-7

Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis

Reliability of the self-report version of the panic disorder severity scale

Internet cognitivebehavioural treatment for panic disorder: randomised controlled trial and evidence of effectiveness in primary care

Development of a short form Social Interaction Anxiety (SIAS) and Social Phobia Scale (SPS) using nonparametric item response theory: the SIAS-6 and SPS-6

Short screening scales to monitor population prevalences and trends in non-specific psychological distress

The anxiety disease. Scribner, (NY): Bantam Books

Development and validation of a revised short version of the working alliance inventory

Measurement of symptom change following web-based psychotherapy: statistical characteristics and analytical methods for interpreting change

To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health

Trends in psychological distress, depressive episodes and mental health treatment-seeking in the United States

Statistics Canada Catalogue

Mental wellness in Canada's Aboriginal communities: striving toward reconciliation

Gender-related patterns and determinants of recent help-seeking for past-year affective, anxiety and substance use disorders: findings from a national epidemiological survey

Effectiveness of internetbased cognitive behaviour therapy for panic disorder in routine psychiatric care

Internet cognitive behavioural therapy for mixed anxiety and depression: a randomized controlled trial and evidence of effectiveness in primary care

The effectiveness of online cognitive behavioral treatment in routine clinical practice

Disorder-specific versus transdiagnostic and clinician-guided versus self-guided treatment for major depressive disorder and comorbid anxiety disorders: a randomized controlled trial

Toward measuring effective treatment coverage: critical bottlenecks in quality-and useradjusted coverage for major depressive disorder

World Health Organization. The impact of COVID-19 on mental, neurological and substance user services

Benchmarking outcomes in a public behavioral health setting: feedback as a quality improvement strategy

The authors acknowledge patients, research staff, therapists and managers associated with the Online Therapy Unit at the University of Regina and the Online Therapy Team at the Saskatchewan Health Authority. The authors are indebted to the Saskatchewan Ministry of Health and acknowledge Information Services at the University of Regina, especially Max Ivanov, for his pivotal role in developing the Online Therapy Unit platform.

The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: H.D.H. is the Executive Director of the Online Therapy Unit.

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: H.D.H. is funded by Saskatchewan Ministry of Health to operate the Online Therapy Unit in collaboration with the Saskatchewan Health Authority, who is also provided Ministry of Health funding to employ online therapists. Research on the Wellbeing Course within the Online Therapy Unit resulting in data used in this paper has been funded by the Canadian Institutes of Health Research 

Heather D. Hadjistavropoulos, PhD https://orcid.org/0000-0002-7092-9056 Nickolai Titov, PhD https://orcid.org/0000-0002-7268-729X

Available by contacting the University of Regina.

The supplemental material for this article is available online